Shareholder Votes

Aveanna Healthcare Holdings, Inc. shareholders approved Election of the three Class II directors to the Board of Directors for three-year terms expiring at the 2029 Annual Meeting at the 2026-05-29 meeting.

“Proposal 1: Election of the three Class II directors to the Board of Directors of the Company for three-year terms expiring at the Company’s 2029 Annual Meeting of Stockholders: Votes Votes Broker Director For Withheld Non-Votes Rodney D. Windley 150,079,425 29,567,009 19,773,305 Sam Weil 160,026,278 19,620,156 19,773,305 Steven E. Rodgers 168,380,101 11,266,333 19,773,305”

IMPINJ INC shareholders approved Approval of the 2026 Equity Incentive Plan at the 2026-05-28 meeting.

“Proposal 4. Approval of the 2026 Equity Incentive Plan The stockholders approved a proposal for the approval of the Company’s 2026 Equity Incentive Plan.”

IMPINJ INC shareholders approved Advisory Vote on Compensation of Named Executive Officers at the 2026-05-28 meeting.

“Proposal 3. Advisory Vote on Compensation of Named Executive Officers (“Say-On-Pay”) The stockholders approved a proposal for the approval, on an advisory basis, of the compensation of the Company’s named executive officers.”

IMPINJ INC shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-28 meeting.

“Proposal 2. Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

IMPINJ INC shareholders approved Election of Directors at the 2026-05-28 meeting.

“Proposal 1. Election of Directors The stockholders elected as directors the seven individuals listed below to serve until the Company’s 2027 annual meeting of stockholders, or until their successors are duly elected and qualified.”

CASTLE BIOSCIENCES INC shareholders approved Approval of the Company’s Non-Employee Director Compensation Policy at the 2026-05-28 meeting.

“Proposal 4. Approval of the Company’s Non-Employee Director Compensation Policy The Company’s stockholders approved the Company’s non-employee director compensation policy as described in the Proxy Statement. The final voting results are as follows: For Against Abstain Broker Non-Votes 21,394,330 1,130,133 48,968 2,415,788”

CASTLE BIOSCIENCES INC shareholders approved Approval of the Compensation of the Company’s Named Executive Officers at the 2026-05-28 meeting.

“Proposal 3. Approval of the Compensation of the Company’s Named Executive Officers The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s definitive proxy statement on Schedule 14A, filed with the Securities and Exchange Commission on April 8, 2026 (the “Proxy Statement”). The final voting results are as follows: For Against Abstain Broker Non-Votes 21,280,180 1,281,394 11,857 2,415,788”

CASTLE BIOSCIENCES INC shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2026-05-28 meeting.

“Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection of KPMG LLP by the Audit Committee of the Company’s Board of Directors as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results are as follows: For Against Abstain 24,531,366 445,666 12,187”

CASTLE BIOSCIENCES INC shareholders approved Election of Class I Directors at the 2026-05-28 meeting.

“Proposal 1. Election of Directors The Company’s stockholders elected the three individuals listed below as Class I Directors, each to serve until the Company’s 2029 annual meeting of stockholders and until their successors are duly elected and qualified. The final voting results are as follows: For Withhold Broker Non-Votes Ellen Goldberg 15,455,265 7,118,166 2,415,788 Miles D. Harrison 15,607,369 6,966,062 2,415,788 Tiffany P. Olson 14,380,655 8,192,776 2,415,788”

Enveric Biosciences, Inc. shareholders approved Ratification of appointment of CBIZ CPAs P.C. as independent auditor at the 2026-05-28 meeting.

“5. The votes cast on the Auditor Ratification Proposal were as follows: Votes Against Abstentions 960,728 19,347 11,753”

Enveric Biosciences, Inc. shareholders rejected Authorized Stock Increase Proposal at the 2026-05-28 meeting.

“4. The votes cast on the Authorized Stock Increase Proposal were as follows: Votes Against Abstentions 427,158 555,147 9,523”

Enveric Biosciences, Inc. shareholders approved Reverse Stock Split Proposal at the 2026-05-28 meeting.

“3. The votes cast on the Reverse Stock Split Proposal were as follows: Votes Against Abstentions 793,344 190,175 8,309”

Enveric Biosciences, Inc. shareholders approved Say-on-Pay Proposal at the 2026-05-28 meeting.

“2. The votes cast on the advisory vote for the Say-on-Pay Proposal were as follows: Votes Against Abstentions Broker Non-Votes 569,552 26,884 5,297 390,095”

Enveric Biosciences, Inc. shareholders approved Election of Directors at the 2026-05-28 meeting.

“1. The votes cast on the Election of Directors were as follows: Nominee Votes For Withheld Broker Non-Votes Michael Webb 564,143 37,590 390,095 George Kegler 531,522 70,211 390,095 Frank Pasqualone 531,937 69,796 390,095 Marcus Schabacker, M.D., Ph.D. 566,038 35,695 390,095 Joseph Tucker, Ph.D. 565,386 36,347 390,095 Sheila DeWitt, Ph.D 565,534 36,199 390,095”

Ellington Financial Inc. shareholders approved Approval of the Equity Incentive Plan.

“Proposal 4: Approval of the Equity Incentive Plan Votes on a proposal to approve the Equity Incentive Plan were as follows: For Against Abstentions Broker Non-Votes 55,004,182 2,837,889 887,986 33,067,881”

Ellington Financial Inc. shareholders approved Ratification of the Appointment of PricewaterhouseCoopers LLP as Independent Registered Public Accountants at the 2026-12-31 meeting.

“Proposal 3: Ratification of the Appointment of the Company's Independent Registered Public Accountants Votes regarding the proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 were as follows: For Against Abstentions Broker Non-Votes 90,170,282 880,741 746,915 *”

Ellington Financial Inc. shareholders approved Advisory (Non-Binding) Vote to Approve Executive Compensation.

“Proposal 2: Advisory (Non-Binding) “Say on Pay” Vote to Approve Executive Compensation Votes on a proposal to approve, on an advisory basis, the compensation of the Company's named executive officers were as follows: For Against Abstentions Broker Non-Votes 54,695,130 3,273,132 761,795 33,067,881”

Ellington Financial Inc. shareholders approved Election of five directors.

“Proposal 1: Election of Directors Votes regarding the election of five directors, each of whom was elected for a term expiring at the 2027 annual meeting or until such time as his or her successor is elected and qualified, were as follows: For Withheld Broker Non-Votes Stephen J. Dannhauser 48,401,715 10,328,342 33,067,881 Lisa Mumford 56,886,550 1,843,507 33,067,881 Laurence E. Penn 56,661,780 2,068,277 33,067,881 Edward Resendez 55,950,937 2,779,120 33,067,881 Ronald I. Simon, Ph.D. 55,333,825 3,396,232 33,067,881”

Otis Worldwide Corp shareholders rejected Reporting on political contributions and expenditures at the 2026-05-27 meeting.

“4) A proposal regarding reporting on political contributions and expenditures. The proposal was not approved and the voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 145,402,369 173,399,850 2,390,116 24,396,658”

Otis Worldwide Corp shareholders approved Ratification of PricewaterhouseCoopers LLP as independent auditor at the 2026-05-27 meeting.

“3) A proposal to appoint PricewaterhouseCoopers LLP, a firm of independent registered public accountants, to serve as Otis’ Independent Auditor for 2026 until the next annual meeting in 2027. The proposal was approved and the voting results are as follows: Votes For Votes Against Abstentions 344,841,469 450,913 296,611”

Otis Worldwide Corp shareholders approved Advisory vote on executive compensation at the 2026-05-27 meeting.

“2) A proposal that shareholders approve, on an advisory basis, the compensation of Otis’ named executive officers. The proposal was approved and the voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 300,604,166 19,385,429 1,202,740 24,396,658”

Otis Worldwide Corp shareholders approved Election of Directors at the 2026-05-27 meeting.

“1) The following individuals were elected to serve as directors for a term expiring at the 2027 Annual Meeting of Shareholders or upon the election and qualification of their successors. The voting results for each nominee are as follows: Nominee Votes For Votes Against Abstentions Broker Non-Votes Thomas A. Bartlett 311,046,915 9,810,622 334,798 24,396,658 Jeffrey H. Black 318,253,873 2,603,882 334,580 24,396,658 Jill C. Brannon 319,869,225 766,259 556,851 24,396,658 Nelda J. Connors 310,438,542 10,423,191 330,602 24,396,658 Kathy Hopinkah Hannan 319,143,881 1,710,655 337,799 24,396,658 Christopher J. Kearney 320,204,663 653,030 334,642 24,396,658 Judith F. Marks 306,737,433 12,890,163 1,564,739 24,396,658 Margaret M. V. Preston 318,085,969 2,775,235 331,131 24,396,658 Shelley Stewart, Jr. 311,526,935 9,091,669 573,731 24,396,658 John H. Walker 311,800,135 9,042,045 350,155 24,396,658”

Freshworks Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-05-28 meeting.

“Proposal 4 - Ratification of Independent Registered Public Accounting Firm . The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the vote were: For Against Abstain 536,542,293 485,331 608,248”

Freshworks Inc. shareholders approved Advisory Vote on the Frequency of Solicitation of Advisory Stockholder Approval of Executive Compensation at the 2026-05-28 meeting.

“Proposal 3 – Advisory Vote on the Frequency of Solicitation of Advisory Stockholder Approval of Executive Compensation . The Company’s stockholders approved, on an advisory basis, every year as the preferred frequency for solicitation of advisory stockholder approval of the compensation paid to the Company’s named executive officers. The results of the vote were: 1 Year 2 Years 3 Years Abstain 407,923,812 94,950 13,834,261 59,071,816”

Freshworks Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-05-28 meeting.

“Proposal 2 - Advisory Vote on Executive Compensation . The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 9, 2026. The results of the vote were: For Against Abstain Broker Non-Vote 378,163,671 57,050,773 45,710,395 56,711,033”

Freshworks Inc. shareholders approved Election of Class II Directors at the 2026-05-28 meeting.

“The Company’s stockholders elected each of the following Class II director nominees to hold office until the Company’s 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, or removal. The results of the vote were: Nominee For Withhold Broker Non-Vote Roxanne S. Austin 439,321,400 41,603,439 56,711,033 Sameer Gandhi 447,757,472 33,167,367 56,711,033 Frank Pelzer 475,795,589 5,129,250 56,711,033 Dennis Woodside 476,555,679 4,369,160 56,711,033”

BRUKER CORP shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-05-21 meeting.

“The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2026 was approved based on the following votes: For Against Abstain 138,544,738 618,216 29,744”

BRUKER CORP shareholders approved Advisory Vote on the 2025 Compensation of Named Executive Officers at the 2026-05-21 meeting.

“The proposal to approve, on an advisory basis, the 2025 compensation of the named executive officers as disclosed in the Company’s proxy statement for the 2026 Annual Meeting was approved based on the following votes: For Against Abstain Broker Non-Votes 127,190,553 5,748,270 60,390 6,193,485”

BRUKER CORP shareholders approved Election of Directors at the 2026-05-21 meeting.

“The following director nominees were elected to serve as Class II members of the Company’s board of directors, each to serve for a three-year term until the Company’s 2029 Annual Meeting of Stockholders and until his or her respective successor is duly elected and qualified based on the following votes : Nominees for Class II director: For Withheld Broker Non-Votes Laura A. Francis 136,149,316 4,841,094 6,193,485 John J. (Jack) Phillips 139,036,356 1,954,054 6,193,485 Hermann F. Requardt, Ph.D. 129,777,851 11,212,559 6,193,485”

Talkspace, Inc. shareholders rejected Advisory (non-binding) vote on compensation that may be paid or become payable to named executive officers in connection with the Merger at the 2026-05-29 meeting.

“2. Proposal to approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company’s named executive officers in connection with the consummation of the Merger (the “ Advisory Compensation Proposal ”), as described in the Proxy Statement. Set forth below are the voting results for the Advisory Compensation Proposal, which was not approved by the Company’s common stockholders, receiving the affirmative vote of approximately 41.98% of the votes cast (excluding abstentions and broker non-votes) by the Company’s stockholders on the Advisory Compensation Proposal at the Special Meeting. Votes For Votes Against Abstentions Broker Non-Votes 51,824,667.14 68,627,520 2,990,303 —”

Talkspace, Inc. shareholders approved Adoption of Agreement and Plan of Merger with Universal Health Services, Inc. at the 2026-05-29 meeting.

“1. Proposal to adopt the Agreement and Plan of Merger, dated as of March 9, 2026 (the “ Merger Agreement ”), by and among the Company, Universal Health Services, Inc., a Delaware corporation (“ UHS ”), UHS Merger Subsidiary, Inc., a Delaware corporation and an indirect wholly owned subsidiary of UHS (“ Merger Sub ”), pursuant to which and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company (the “ Merger ”), with the Company continuing as the surviving corporation in the Merger as an indirect wholly owned subsidiary of UHS (the “ Merger Proposal ”), as described in the Proxy Statement. Set forth below are the voting results for the Merger Proposal, which was approved by the Company’s common stockholders, receiving the affirmative vote of approximately 73.48% of the shares of the Company’s common stock outstanding and entitled to vote at the Special Meeting. Votes For Votes Against Abstentions Broker Non-Votes 123,082,042.14 331,508 28,940 —”

Roblox Corp shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-05-28 meeting.

“3. The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 1,490,336,780 679,612 377,045 -”

Roblox Corp shareholders approved Advisory vote to approve executive compensation at the 2026-05-28 meeting.

“2. The stockholders elected to approve, on a non-binding advisory basis, the compensation paid to the Company’s named executive officers. The voting results were as follows: Votes For Votes Against Abstentions Broker Non-Votes 1,194,982,853 223,616,817 290,518 72,503,250”

Roblox Corp shareholders approved Election of three directors to serve until the 2029 annual meeting of stockholders at the 2026-05-28 meeting.

“1. The stockholders elected the three individuals listed below as directors to serve on the board of directors of the Company, each to serve until the 2029 annual meeting of stockholders or until her or his successor is duly elected and qualified or until her or his earlier death, resignation or removal. The voting results were as follows: Name Votes For Votes Withheld Broker Non-Votes David Baszucki 1,332,589,368 86,300,820 72,503,250 Gregory Baszucki 1,329,332,647 89,557,541 72,503,250 Dennis Durkin 1,408,454,089 10,436,099 72,503,250”

Venture Global, Inc. shareholders approved Ratification of Selection of the Company’s Independent Registered Public Accounting Firm for 2026 at the 2026-05-27 meeting.

“2. Proposal 2 – Ratification of Selection of the Company’s Independent Registered Public Accounting Firm for 2026. Shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2026.”

Venture Global, Inc. shareholders approved Election of Directors at the 2026-05-27 meeting.

“The final voting results of the matters presented at the 2026 Annual Meeting of Shareholders are set forth below. 1. Proposal 1 - Election of Directors. Shareholders elected all 7 director nominees named in the 2026 Proxy Statement to the Company’s Board of Directors (the “Board”) to serve until the Company’s 2027 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified, or until such director’s earlier death, disqualification, resignation or removal.”

WINTRUST FINANCIAL CORP shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-05-28 meeting.

“Proposal No. 3 — Ratification of Independent Registered Public Accounting Firm Votes For Votes Against Abstentions Broker Non-Votes 57,552,404 4,249,760 27,921 —”

WINTRUST FINANCIAL CORP shareholders approved Advisory Vote on 2025 Executive Compensation at the 2026-05-28 meeting.

“Proposal No. 2 — Advisory Vote on 2025 Executive Compensation Votes For Votes Against Abstentions Broker Non-Votes 56,857,769 1,623,123 75,966 3,273,227”

WINTRUST FINANCIAL CORP shareholders approved Election of twelve director nominees at the 2026-05-28 meeting.

“Proposal No. 1 — Election of Directors Votes For Votes Against Abstentions Broker Non-Votes Elizabeth H. Connelly 57,703,405 819,291 34,162 3,273,227 Timothy S. Crane 58,398,500 135,796 22,562 3,273,227 Peter D. Crist 55,192,285 3,343,601 20,972 3,273,227 Marla F. Glabe 56,625,990 1,900,267 30,601 3,273,227 Brian A. Kenney 57,923,346 602,517 30,995 3,273,227 Laura A. Kohl 58,389,726 135,956 31,176 3,273,227 Deborah L. Hall Lefevre 57,232,200 1,189,049 135,609 3,273,227 Suzet M. McKinney 57,743,798 781,624 31,436 3,273,227 David S. Richter 58,395,799 127,770 33,289 3,273,227 Gregory A. Smith 57,937,355 585,492 34,011 3,273,227 Karin Gustafson Teglia 57,733,221 790,300 33,337 3,273,227 Alex E. Washington, III 57,088,273 1,434,938 33,647 3,273,227”

EXELIXIS, INC. shareholders approved Advisory approval of executive compensation (Say on Pay) at the 2026-05-26 meeting.

“4. Approval, on an advisory basis, of the compensation of Exelixis’ named executive officers, as disclosed in the Proxy Statement (Say on Pay): Exelixis stockholders approved the Say on Pay proposal. FOR AGAINST ABSTAIN BROKER NON-VOTES 163,104,135 43,156,553 329,618 22,436,080”

EXELIXIS, INC. shareholders approved Approval of the 2017 Plan at the 2026-05-26 meeting.

“3. Approval of the 2017 Plan: Exelixis stockholders approved the 2017 Plan. FOR AGAINST ABSTAIN BROKER NON-VOTES 196,926,657 9,343,837 319,812 22,436,080”

EXELIXIS, INC. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm at the 2026-05-26 meeting.

“2. Ratification of Ernst & Young LLP as Exelixis’ independent registered public accounting firm: Exelixis stockholders ratified the selection of Ernst & Young LLP as Exelixis’ independent registered public accounting firm for the fiscal year ending January 1, 2027. FOR AGAINST ABSTAIN BROKER NON-VOTES 222,343,120 6,485,691 197,575 —”

EXELIXIS, INC. shareholders approved Election of 11 directors at the 2026-05-26 meeting.

“1. Election of Directors: Exelixis stockholders elected the following 11 directors to serve until the next annual meeting of stockholders in 2027, and until his or her successor is elected and qualified, or until his or her earlier death, resignation or removal: FOR AGAINST ABSTAIN BROKER NON-VOTES Mary C. Beckerle, Ph.D. 204,854,581 1,538,523 197,202 22,436,080 S. Gail Eckhardt, M.D. 205,409,482 1,022,879 157,945 22,436,080 Maria C. Freire, Ph.D. 180,367,648 26,067,310 155,348 22,436,080 Tomas J. Heyman 200,508,205 5,902,008 180,093 22,436,080 David E. Johnson 205,319,312 1,096,455 174,539 22,436,080 Michael M. Morrissey, Ph.D. 204,731,180 1,692,296 166,830 22,436,080 Robert L. Oliver, Jr. 205,297,039 1,137,865 155,402 22,436,080 Stelios Papadopoulos, Ph.D. 198,500,120 7,922,275 167,911 22,436,080 George Poste, DVM, Ph.D., FRS 204,405,453 2,023,314 161,539 22,436,080 Julie Anne Smith 202,976,810 3,456,942 156,554 22,436,080 Jack L. Wyszomierski 201,891,192 4,536,760 162,354 22,436,080”

Sunshine Biopharma Inc. shareholders approved to the voluntary adjustment, from time to time, of the exercise price of any and all currently outstanding Series C Warrants pursuant to Section 3.8 of the Series C Warrants. at the 2026-05-28 meeting.

“to the voluntary adjustment, from time to time, of the exercise price of any and all currently outstanding Series C Warrants pursuant to Section 3.8 of the Series C Warrants.”

Sunshine Biopharma Inc. shareholders approved to any adjustment to the exercise price or number of shares of common stock underlying the Series C Warrants issued in the Offering in the event of a Share Combination Event pursuant to Section 3.7 of the Series C Warrants. at the 2026-05-28 meeting.

“to any adjustment to the exercise price or number of shares of common stock underlying the Series C Warrants issued in the Offering in the event of a Share Combination Event pursuant to Section 3.7 of the Series C Warrants.”

Sunshine Biopharma Inc. shareholders approved to issue in excess of twenty percent (20%) of the outstanding shares of the Company’s common stock at a deemed discount to the Nasdaq Minimum Price (as defined in Nasdaq Listing Rule 5635(d)(1)(A)) immediately prior to execution of the Placement Agent Agreement for the Company’s public offering that at the 2026-05-28 meeting.

“to issue in excess of twenty percent (20%) of the outstanding shares of the Company’s common stock at a deemed discount to the Nasdaq Minimum Price (as defined in Nasdaq Listing Rule 5635(d)(1)(A)) immediately prior to execution of the Placement Agent Agreement for the Company’s public offering that closed on May 19, 2026 (the “Offering”).”

Equillium, Inc. shareholders approved Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 200,000,000 to 400,000,000 shares. at the 2026-05-28 meeting.

“Proposal 4. Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation. The Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from 200,000,000 to 400,000,000 shares. The final voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 42,687,545 11,570,307 29,477 0”

Equillium, Inc. shareholders approved Ratification of the appointment of the independent registered public accounting firm. at the 2026-05-28 meeting.

“Proposal 3. Ratification of the appointment of the independent registered public accounting firm. The Company’s stockholders ratified the appointment by the Audit Committee of the Company’s Board of Directors of Crowe LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 54,274,675 5,234 7,420 0”

Equillium, Inc. shareholders approved Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split. at the 2026-05-28 meeting.

“Proposal 2. Approval of an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split. The Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company’s common stock at a ratio in the range of 1-for-2 to 1-for-20, inclusive, with such ratio to be determined in the discretion of the Company’s Board of Directors and with such reverse stock split to be effected at such time and date, if at all, as determined by the Company’s Board of Directors in its sole discretion. The final voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 52,697,618 1,559,976 29,735 0”

Equillium, Inc. shareholders approved Election of directors. at the 2026-05-28 meeting.

“Proposal 1. Election of directors. The Company’s stockholders elected the two persons listed below as Class II directors, each to serve until the Company’s 2029 Annual Meeting of Stockholders and until their respective successor has been duly elected and qualified, or until their earlier death, resignation or removal. Former director Peter Colabuono was not renominated as a director and his term ended at the Annual Meeting. In connection with the expiration of Mr. Colabuono’s term, the Company reduced the size of the Board of Directors from seven directors to six directors. The final voting results are as follows: Name Votes For Votes Withheld Broker Non- Votes Charles McDermott 36,072,238 10,018,889 8,196,202 Bruce Steel 45,955,052 136,075 8,196,202”